68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors

Clinical trial NCT03001349 · TERMINATED

Trial details

NCT number: NCT03001349
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Meningioma Metastatic Well Differentiated Neuroendocrine Neoplasm Multiple Endocrine Neoplasia Type 1 Neuroendocrine Neoplasm Somatostatin Positive Neoplastic Cells Present Von Hippel-Lindau Syndrome

Start date: 2017-05-16
Primary completion: 2021-02-05
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.